SCHEMBL24019794

SCHEMBL24019794

O=C(CSc1nnnn1-c1ccc(CO)cc1)c1ccc(C(F)(F)F)cc1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 7/20 0.61
▸ ALDH1A1 P00352 7/20 0.55
▸ MEN1 O00255 6/20 0.55
▸ KMT2A Q03164 6/20 0.55
▸ POLB P06746 5/20 0.55
▸ ALPL P05186 4/20 0.55
▸ ALPG P10696 4/20 0.55
▸ LMNA P02545 4/20 0.55
▸ SMN1; SMN2 Q16637 4/20 0.55
▸ KDM4E B2RXH2 3/20 0.55
▸ GAA P10253 3/20 0.55
▸ RECQL P46063 3/20 0.55
▸ JAK2 O60674 2/20 0.55
▸ USP2 O75604 2/20 0.55
▸ L3MBTL1 Q9Y468 3/20 0.53
▸ THRB P10828 1/20 0.53
▸ APEX1 P27695 1/20 0.53
▸ TDP1 Q9NUW8 1/20 0.53
▸ TSHR P16473 4/20 0.52
▸ HPGD P15428 2/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21952095 0.89 MAPT (0.64) MAPTALDH1A1MEN1KMT2APOLB
SCHEMBL27303528 0.84 ALPG (0.78) MAPTALDH1A1MEN1KMT2APOLB
SCHEMBL30620388 0.84 ALPG (0.78) MAPTALDH1A1MEN1KMT2APOLB
SCHEMBL21951986 0.79 MAPT (0.71) MAPTALDH1A1MEN1KMT2APOLB
SCHEMBL24209668 0.78 MAPT (0.60) MAPTALDH1A1MEN1KMT2APOLB
SCHEMBL30296082 0.77 CPB1 (0.50) MAPTALDH1A1MEN1KMT2APOLB
SCHEMBL21952054 0.76 MAPT (0.64) MAPTALDH1A1MEN1KMT2APOLB
SCHEMBL24209657 0.76 MAPT (0.82) MAPTALDH1A1MEN1KMT2APOLB
SCHEMBL29509840 0.76 MAPT (1.00) MAPTALDH1A1MEN1KMT2APOLB
SCHEMBL24209682 0.76 MAPT (0.71) MAPTALDH1A1MEN1KMT2APOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3909577-A1 UBIQUITIN-LIGASE INHIBITORS FOR THE TREATMENT OF CANCER Fundación Profesor Novoa Santos (ES) 2021-11-17 — — EP disclosed
Send feedback